Modified Alginates for Anti-Fibrotic Materials and Applications
Invention type: Technology
/
Case number: #21323JQ
Covalently modified alginate polymers, possessing enhanced biocompatibility and tailored physiochemical properties, as well as methods of making and use thereof, are disclosed herein. The covalently modified alginates are useful as a matrix for coating of any material where reduced fibrosis is desired, such as encapsulated cells for transplantation and medical devices implanted or used in the body.
Researchers
Robert Langer
/
Omid Veiseh
/
Joshua Doloff
/
Arturo Vegas
/
Minglin Ma
/
Daniel Anderson
Departments: Office of the Institute Professors, Department of Chemical Engineering
Technology Areas: Biomaterials & Bioelectronics: Medical Device Coatings, Tissue Repair / Biotechnology: Tissue Engineering / Chemicals & Materials: Polymers / Therapeutics: Regenerative Medicine
Impact Areas: Healthy Living
-
modified alginates for anti-fibrotic materials and applications
Italy | Granted | 3,368,085 -
modified alginates for use as anti-fibrotic materials
United States of America | Granted | 10,709,818 -
modified alginates for anti-fibrotic materials and applications
United States of America | Granted | 10,729,818 -
modified alginates for anti-fibrotic materials and applications
Mexico | Granted | 404,406 -
modified alginates for anti-fibrotic materials and applications
New Zealand | Granted | 742,800 -
modified alginates for anti-fibrotic materials and applications
India | Granted | 522,851 -
modified alginates for anti-fibrotic materials and applications
Singapore | Pending -
modified alginates for anti-fibrotic materials and applications
South Africa | Granted | 2,018 -
modified alginates for anti-fibrotic materials and applications
European Patent Convention | Granted | 3,368,085 -
modified alginates for anti-fibrotic materials and applications
United States of America | Granted | 11,090,413 -
modified alginates for anti-fibrotic materials and applications
United States of America | Published application -
modified alginates for anti-fibrotic materials and applications
Russian Federation | Pending -
modified alginates for anti-fibrotic materials and applications
Hong Kong | Granted | 1,260,309 -
modified alginates for anti-fibrotic materials and applications
United States of America | Granted | 12,097,307 -
modified alginates for anti-fibrotic materials and applications
Belgium | Granted | 3,368,085 -
modified alginates for anti-fibrotic materials and applications
Switzerland | Granted | 3,368,085 -
modified alginates for anti-fibrotic materials and applications
Germany | Granted | 3,368,085 -
modified alginates for anti-fibrotic materials and applications
Denmark | Granted | 3,368,085 -
modified alginates for anti-fibrotic materials and applications
Spain | Granted | 3,368,085 -
modified alginates for anti-fibrotic materials and applications
France | Granted | 3,368,085 -
modified alginates for anti-fibrotic materials and applications
United Kingdom | Granted | 3,368,085 -
modified alginates for anti-fibrotic materials and applications
Ireland | Granted | 3,368,085
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.